Profile: Alligator Bioscience AB is a drug discovery and development company focused on the optimization of biopharmaceuticals using the protein optimization technology Find® (fragment induced diversity). Our ADC-1004 drug candidate is optimized using our Find® technology to suit treatments of ischemia reperfusion (I/R) injury. Our ADC-1001 is a Find® optimized interleukin-1 receptor antagonist with enhanced receptor affinity compared to the wild type IL-1Ra protein, which is suitable for the treatment of any IL-1-driven condition.